Reaching the population with dementia drugs: what are the challenges?

Reaching the population with dementia drugs: what are the challenges?

Item
http://www.wikidata.org/entity/Q36961300
What are the benefits of cognitive enhancers for Alzheimer's Disease: use of Population Impact Measures.Pharmacological treatment of Alzheimer's disease: effect of race and demographic variablesPrion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stagePlasma alkaline phosphatase is elevated in Alzheimer's disease and inversely correlates with cognitive function.Observational cohort study: deprivation and access to anti-dementia drugs in the UK.The effect of dementia trends and treatments on longevity and disability: a simulation model based on the MRC Cognitive Function and Ageing Study (MRC CFAS).Social class, dementia and the fourth age.Antidementia drugs: prescription by level of cognitive impairment or by socio-economic group?
P2860

Reaching the population with dementia drugs: what are the challenges?

Item
http://www.wikidata.org/entity/Q36961300
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Reaching the population with dementia drugs: what are the challenges?
@en
type
label
Reaching the population with dementia drugs: what are the challenges?
@en
prefLabel
Reaching the population with dementia drugs: what are the challenges?
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Reaching the population with dementia drugs: what are the challenges?
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932